mGluR5 Positive and Negative Allosteric Modulators Differentially Affect Dendritic Spine Density and Morphology in the Prefrontal Cortex

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|14|4|476-485

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.14, Iss.4, 2015-05, pp. : 476-485

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Positive Allosteric Modulators (PAMs) of Metabotropic Glutamate Receptor 5 (mGluR5) Attenuate Microglial Activation

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 4, 2014-06 ,pp. : 558-566

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery of Positive Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 (mGluR5)

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 9, 2005-08 ,pp. : 825-846

Bentham Science Publishers

Access to resources Recommend Favorite

mGluR5 Negative Allosteric Modulators Overview: A Medicinal Chemistry Approach Towards a Series of Novel Therapeutic Agents

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 6, 2011-03 ,pp. : 680-695

Bentham Science Publishers

Access to resources Recommend Favorite

mGluR4 positive allosteric modulators with potential for the treatment of Parkinson's disease: WO09010455

By East Stephen P   Gerlach Kai  

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 3, 2010-03 ,pp. : 441-445

Informa Healthcare

Access to resources Recommend Favorite

mGluR2 positive allosteric modulators: a patent review (2009 – present)

By Trabanco Andrés A   Cid José María  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 5, 2013-05 ,pp. : 629-647

Informa Healthcare

Access to resources Recommend Favorite